BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 7011013)

  • 1. Insulin secretion in diabetes mellitus.
    Pfeifer MA; Halter JB; Porte D
    Am J Med; 1981 Mar; 70(3):579-88. PubMed ID: 7011013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man.
    Pfeifer MA; Halter JB; Judzewitsch RG; Beard JC; Best JD; Ward WK; Porte D
    Diabetes Care; 1984; 7 Suppl 1():25-34. PubMed ID: 6376026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of insulin secretion in diabetes mellitus.
    Ward WK; Beard JC; Halter JB; Porte D
    Adv Exp Med Biol; 1985; 189():137-58. PubMed ID: 3898762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose regulation in non-insulin-dependent diabetes mellitus. Interaction between pancreatic islets and the liver.
    Halter JB; Ward WK; Porte D; Best JD; Pfeifer MA
    Am J Med; 1985 Aug; 79(2B):6-12. PubMed ID: 2863979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms for hyperglycemia in type II diabetes mellitus: therapeutic implications for sulfonylurea treatment--an update.
    Porte D; Kahn SE
    Am J Med; 1991 Jun; 90(6A):8S-14S. PubMed ID: 1872310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus.
    Ward WK; Beard JC; Halter JB; Pfeifer MA; Porte D
    Diabetes Care; 1984; 7(5):491-502. PubMed ID: 6094129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet dysfunction in non-insulin-dependent diabetes mellitus.
    Kahn SE; Porte D
    Am J Med; 1988 Nov; 85(5A):4-8. PubMed ID: 3057894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms.
    Rabuazzo AM; Buscema M; Vinci C; Caltabiano V; Vetri M; Forte F; Vigneri R; Purrello F
    Endocrinology; 1992 Oct; 131(4):1815-20. PubMed ID: 1396327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Banting lecture 1990. Beta-cells in type II diabetes mellitus.
    Porte D
    Diabetes; 1991 Feb; 40(2):166-80. PubMed ID: 1991568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphoinositide hydrolysis and insulin secretion in response to glucose stimulation are impaired in isolated rat islets by prolonged exposure to the sulfonylurea tolbutamide.
    Zawalich WS
    Endocrinology; 1989 Jul; 125(1):281-6. PubMed ID: 2544404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets.
    Panten U; Burgfeld J; Goerke F; Rennicke M; Schwanstecher M; Wallasch A; Zünkler BJ; Lenzen S
    Biochem Pharmacol; 1989 Apr; 38(8):1217-29. PubMed ID: 2650685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stimulation of insulin secretion by tolbutamide. Studies on experimental diabetes].
    Ammon HP
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1675-6. PubMed ID: 4150009
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological interventions that directly stimulate or modulate insulin secretion from pancreatic beta-cell: implications for the treatment of type 2 diabetes.
    Farret A; Lugo-Garcia L; Galtier F; Gross R; Petit P
    Fundam Clin Pharmacol; 2005 Dec; 19(6):647-56. PubMed ID: 16313276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose.
    Judzewitsch RG; Pfeifer MA; Best JD; Beard JC; Halter JB; Porte D
    J Clin Endocrinol Metab; 1982 Aug; 55(2):321-8. PubMed ID: 7045153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus.
    Del Prato S; Tiengo A
    Diabetes Metab Res Rev; 2001; 17(3):164-74. PubMed ID: 11424229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of sulfonylurea stimulation of insulin release.
    Hellman B
    Acta Biol Med Ger; 1982; 41(12):1211-9. PubMed ID: 6765162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interacting effects of sulfonylureas and glucose on cyclic AMP metabolism and insulin release in pancreatic islets of the rat.
    Grill V; Cerasi E
    J Clin Invest; 1978 May; 61(5):1346-54. PubMed ID: 207736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose regulation of insulin secretion independent of the opening or closure of adenosine triphosphate-sensitive K+ channels in beta cells.
    Sato Y; Anello M; Henquin JC
    Endocrinology; 1999 May; 140(5):2252-7. PubMed ID: 10218978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inexhaustible beta cell.
    Vinik AI; Kalk WJ; Botha JL; Jackson WP; Blake KC
    Diabetes; 1976 Jan; 25(1):11-5. PubMed ID: 1107093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.